2Parers A, Caballeria L, Rahahi N, et al, Bio- chemical response to ursodeoxy chdic acid and Cong-term prog- nosis in 'primanmary biliary cirrhosis[J]. Hepatology, 2006, 130:715-720.
3Corpechot C, Abenavoli L, Rabahi N, et al. Bio- chemical response to ursodeoxycholie acid and lony-term prognosis in primary biliany cirrhosis[ J] . Hepatology, 2008, 48:871-877.
4Hesthcote Ej. Manngement of primary biliary cir- rhosi. The American Association for the srudy of live Diseases practice guidelines[J]. Hepatology , 2000,31 :1005-1013.
1Hesthcote Ej.Management of primary biliary cirrhosis[J].The American Association for the study og liver Diseases practice guidelines Hepatology 2000,(31):1005-1013.
2Kaplan MM,Poupon R.Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.Hepatology,2009,50:652.
9Bogdanos DP,Komorowski L.Disease-specific autoantibodies in primary biliary cirrhosis.Clin Chim Acta,2011,412:502-512.
10Granito A,Yang WH,Muratori L,et al.PML nuclear body component Spl40 is a novel autoantigen in primary biliary cirrhosis.Am J Gastroenterol,2010,105:125-131.
